Preclinical data for Droloxifene
- 15 September 1994
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 84 (2) , 101-116
- https://doi.org/10.1016/0304-3835(94)90364-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Pharmacologic and Biologic Properties of Droloxifene, A New AntiestrogenAmerican Journal of Clinical Oncology, 1991
- Mechanism of Action of High-Affinity Antiestrogens An OverviewAmerican Journal of Clinical Oncology, 1991
- Tamoxifen for breast cancer: Associated endometrial cancerCancer, 1990
- TamoxifenDrugs, 1989
- Effect of continuous vs intermittent application of 3-OH-tamoxifen or tamoxifen on the proliferation of the human breast cancer cell line MCF-7 M1Zeitschrift für Krebsforschung und Klinische Onkologie, 1989
- ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERSThe Lancet, 1989
- Pharmacology and Toxicology of the Antiestrogen DroloxifenePublished by S. Karger AG ,1986
- No loss of estrogenic or anti-estrogenic activity after demethylation of droloxifene (3-OH-Tamoxifen)International Journal of Cancer, 1985
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984
- Tamoxifen flare in advanced breast cancerJAMA, 1978